Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bettina Trinschek

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cells|September 26, 2025
Impaired PTEN Expression in T Cells Drives Resistance to Treg-Mediated Immune Regulation in Multiple SclerosisJanine Schlöder, Bettina Trinschek, Felix Luessi, et al.
Frontiers in Immunology|December 24, 2015
Translating Treg Therapy in Humanized MiceSusanne A Hahn, Iris Bellinghausen, Bettina Trinschek, et al.
International Journal of Molecular Sciences|July 21, 2015
Interferon-Beta Therapy of Multiple Sclerosis Patients Improves the Responsiveness of T Cells for Immune Suppression by Regulatory T CellsBettina Trinschek, Felix Luessi, Catharina C Gross, et al.
Frontiers in Immunology|April 9, 2013
Costimulatory molecules on immunogenic versus tolerogenic human dendritic cellsMario Hubo, Bettina Trinschek, Fanny Kryczanowsky, et al.
Plos One|October 25, 2013
Kinetics of IL-6 production defines T effector cell responsiveness to regulatory T cells in multiple sclerosisBettina Trinschek, Felix Luessi, Felix Lüssi, et al.
International Immunopharmacology|December 10, 2013
Cladribine exerts an immunomodulatory effect on human and murine dendritic cellsStefan H P Kraus, Felix Luessi, Bettina Trinschek, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|May 4, 2013
Subclinical CNS inflammation as response to a myelin antigen in humanized miceMorad Zayoud, Khalifa El Malki, Katrin Frauenknecht, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 4, 2015
FTY720 (fingolimod) treatment tips the balance towards less immunogenic antigen-presenting cells in patients with multiple sclerosisFelix Luessi, Stefan Kraus, Bettina Trinschek, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cells|September 26, 2025
Impaired PTEN Expression in T Cells Drives Resistance to Treg-Mediated Immune Regulation in Multiple SclerosisJanine Schlöder, Bettina Trinschek, Felix Luessi, et al.
Frontiers in Immunology|December 24, 2015
Translating Treg Therapy in Humanized MiceSusanne A Hahn, Iris Bellinghausen, Bettina Trinschek, et al.
International Journal of Molecular Sciences|July 21, 2015
Interferon-Beta Therapy of Multiple Sclerosis Patients Improves the Responsiveness of T Cells for Immune Suppression by Regulatory T CellsBettina Trinschek, Felix Luessi, Catharina C Gross, et al.
Frontiers in Immunology|April 9, 2013
Costimulatory molecules on immunogenic versus tolerogenic human dendritic cellsMario Hubo, Bettina Trinschek, Fanny Kryczanowsky, et al.
Plos One|October 25, 2013
Kinetics of IL-6 production defines T effector cell responsiveness to regulatory T cells in multiple sclerosisBettina Trinschek, Felix Luessi, Felix Lüssi, et al.
International Immunopharmacology|December 10, 2013
Cladribine exerts an immunomodulatory effect on human and murine dendritic cellsStefan H P Kraus, Felix Luessi, Bettina Trinschek, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|May 4, 2013
Subclinical CNS inflammation as response to a myelin antigen in humanized miceMorad Zayoud, Khalifa El Malki, Katrin Frauenknecht, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 4, 2015
FTY720 (fingolimod) treatment tips the balance towards less immunogenic antigen-presenting cells in patients with multiple sclerosisFelix Luessi, Stefan Kraus, Bettina Trinschek, et al.
Pageof 1